_________
false
כן-פייט ביופרמה בע"מ
2
379
CAN-FITE BIOPHARMA LTD
Corporation no:
512022153
14960
Israel Securities Authority
Tel Aviv Stock Exchange
C001
(
Public
)
Reported via MAGNA:
29/08/2024
www.isa.gov.il
www.tase.co.il
Reference:
2024-02-096202
Time of broadcast:
15:16
15:16
Report of Periodic or Interim Report
Regulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
Can-Fite BioPharma Ltd. issued a press release announcing financial results for the six months ended June 30, 2024 and updates on its drug development programs. In addition, on the same day, the Company issued unaudited interim condensed consolidated financial statements as of June 30, 2024
ea021263701-6k_canfiteEDGAR7_Bannerless_isa.pdf
Link to filing on foreign stock exchange (optional):
_________
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
-1
Date of revision of form structure:
06/08/2024
Address:
Bareket
10
,
Petach-Tikva
47190
,
Tel:
03-9241114
,
03-9213501
Fax:
03-9249378
E-mail address:
motti@canfite.co.il
Company site:
www.canfite.com
Previous names of reporting entity:
Name of the Signatory:
FARBSTEIN MORDECHAI
Position of Signatory in the reporting corporation:
Chief Operating Officer & CFO
Name of Employer Company:
Address:
Maharal street
10
,
Tel Aviv
6248110
Telephone:
052-8998671
Facsimile:
E-mail:
Motti@canfite.co.il
1